Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide.
Chowdhury O., O'Sullivan J., Barkas N., Wang G., Buck G., Hamblin A., Tefferi A., Al-Ali HK., Barosi G., Devos T., Gisslinger H., Jiang Q., Kiladjian J-J., Mesa R., Passamonti F., Ribrag V., Schiller G., Vannucchi AM., Zhou D., McMullin MF., Zhong J., Gale RP., Mead AJ., RESUME trialists .